REFERNCES
- Colombo AL, de Almeida Júnior JN, Slavin MA, et al. Candida and
invasive mould diseases in non-neutropenic critically ill patients and
patients with haematological cancer. Lancet Infect. Dis. 2017;17 : e344–e356.
- Russo A, Tiseo G, Falcone M, et al. Pulmonary aspergillosis: an
evolving challenge for diagnosis and treatment. Infect Dis Ther. 2020;9 : 511–524.
- Meersseman W, Lagrou K, Maertens J, et al. Invasive aspergillosis in
the intensive care unit. Clin Infect Dis. 2007; 45 : 205–216.
- Dandachi D, Wilson Dib R, Fernández-Cruz A, et al. Invasive pulmonary
aspergillosis in patients with solid tumours: risk factors and
predictors of clinical outcomes. Ann Med. 2018; 50 : 713–720.
- Ullmann AJ, Aguado JM, Arikan-Akdagli S, et al. Diagnosis and
management of Aspergillus diseases: executive summary of the 2017
ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018; 24 :
e1–e38.
- De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of
invasive fungal disease from the European Organization for Research
and Treatment of Cancer/Invasive Fungal Infections Cooperative Group
and the National Institute of Allergy and Infectious Diseases Mycoses
Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46 : 1813–1821.
- Peghin M, Ruiz-Camps I, Garcia-Vidal C, et al. Unusual forms of
subacute invasive pulmonary aspergillosis in patients with solid
tumors. J Infect. 2014; 69 : 387–395.
- Dandachi D, Wilson Dib R, Fernández-Cruz A, et al. Invasive pulmonary
aspergillosis in patients with solid tumours: risk factors and
predictors of clinical outcomes. Ann Med. 2018; 50 : 713–720.
- Levesque E, Ait-Ammar N, Dudau D, et al. Invasive pulmonary
aspergillosis in cirrhotic patients: analysis of a 10-year clinical
experience. Ann Intensive Care. 2019; 9 : 31.
- Lahmer T, Brandl A, Rasch S, et al. Prevalence and outcome of invasive
pulmonary aspergillosis in critically ill patients with liver
cirrhosis: an observational study. Sci Rep. 2019; 9 : 11919.
- Irvine KM, Ratnasekera I, Powell EE, Hume DA. Causes and consequences
of innate immune dysfunction in cirrhosis [published correction
appears in Front Immunol]. Front Immunol. 2019; 10 : 293.
- Garbino J, Fluckiger U, Elzi L, et al. Survey of aspergillosis in
non-neutropenic patients in Swiss teaching hospitals. Clin Microbiol
Infect. 2011; 17 : 1366–1371.
- Sipsas NV, Kontoyiannis DP. Invasive fungal infections in patients
with cancer in the intensive care unit. Int J Antimicrob Agents. 2012;39 : 464–471.
- Bassetti M, Righi E, De Pascale G, et al. How to manage aspergillosis
in non-neutropenic intensive care unit patients. Crit Care. 2014;18 : 458.
- Dimopoulos G, Frantzeskaki F, Poulakou G, et al. Invasive
aspergillosis in the intensive care unit. Ann N Y Acad Sci. 2012;272 : 31–39.
- Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, et al. Isolation ofAspergillus spp. from the respiratory tract in critically ill
patients: risk factors, clinical presentation and outcome. Crit Care.
2005; 9 : R191–R199.
- Guinea J, Torres-Narbona M, Gijón P, et al. Pulmonary aspergillosis
in, patients with chronic obstructive pulmonary disease: incidence,
risk factors, and outcome. Clin Microbiol Infect. 2010; 16 :
870–877.
- Höfeler H, Popescu O, Kath R, et al. Invasive bronchopulmonary
aspergillosis leading to rapidly progressive respiratory failure in a
patient with severe aplastic anemia. Klin Wochenschr. 1987;65 : 530–532.
- Vail CM, Chiles C. Invasive pulmonary aspergillosis: radiologic
evidence of tracheal involvement. Radiology. 1987; 165 :
745–746.
- Takeda K, Imamura Y, Takazono T, et al. The risk factors for
developing of chronic pulmonary aspergillosis in nontuberculous
mycobacteria patients and clinical characteristics and outcomes in
chronic pulmonary aspergillosis patients coinfected with
nontuberculous mycobacteria. Med Mycol. 2016; 54 : 120–127.
- Hafeez I, Muers MF, Murphy SA, et al. Non-tuberculous mycobacterial
lung infection complicated by chronic necrotising pulmonary
aspergillosis. Thorax. 2000; 55 : 717–719.
- Kunst H, Wickremasinghe M, Wells A, Wilson R. Nontuberculous
mycobacterial disease and Aspergillus-related lung disease in
bronchiectasis. Eur Respir J. 2006; 28 : 352–357.
- Haywood A, Duc J, Good P, et al. Systemic corticosteroids for the
management of cancer-related breathlessness (dyspnoea) in adults.
Cochrane Database Syst Rev. 2019; 2 : CD012704.
- Vayne-Bossert P, Haywood A, Good P, et al. Corticosteroids for adult
patients with advanced cancer who have nausea and vomiting (not
related to chemotherapy, radiotherapy, or surgery). Cochrane Database
Syst Rev. 2017; 7 : CD012002.
- Paulsen O, Klepstad P, Rosland JH, et al. Efficacy of
methylprednisolone on pain, fatigue, and appetite loss in patients
with advanced cancer using opioids: a randomized, placebo-controlled,
double-blind trial. J Clin Oncol. 2014; 32: 3221–3228.
- Dib RW, Khalil M, Fares J, et al. Invasive pulmonary aspergillosis:
comparative analysis in cancer patients with underlying haematologic
malignancies versus solid tumours. J Hosp Infect. 2020; 104 :
358–364.